0.6256
price down icon5.17%   -0.0341
after-market 시간 외 거래: .62 -0.0056 -0.90%
loading
전일 마감가:
$0.6597
열려 있는:
$0.6615
하루 거래량:
1.20M
Relative Volume:
1.32
시가총액:
$53.90M
수익:
$2.24M
순이익/손실:
$-136.67M
주가수익비율:
-0.2732
EPS:
-2.29
순현금흐름:
$-102.08M
1주 성능:
+7.71%
1개월 성능:
+10.47%
6개월 성능:
-30.49%
1년 성능:
-73.71%
1일 변동 폭
Value
$0.614
$0.6699
1주일 범위
Value
$0.5666
$0.675
52주 변동 폭
Value
$0.3418
$2.5199

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
명칭
Century Therapeutics Inc
Name
전화
215-981-4000
Name
주소
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
직원
165
Name
트위터
Name
다음 수익 날짜
2025-03-19
Name
최신 SEC 제출 서류
Name
IPSC's Discussions on Twitter

IPSC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IPSC
Century Therapeutics Inc
0.6256 56.84M 2.24M -136.67M -102.08M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-08 개시 Rodman & Renshaw Buy
2023-08-28 다운그레이드 JP Morgan Overweight → Neutral
2022-12-27 개시 Chardan Capital Markets Buy
2022-10-31 개시 Guggenheim Buy
2022-10-10 개시 Canaccord Genuity Buy
2022-05-23 개시 H.C. Wainwright Buy
2022-05-12 개시 William Blair Mkt Perform
2021-07-13 개시 BofA Securities Buy
2021-07-13 개시 JP Morgan Overweight
2021-07-13 개시 Piper Sandler Overweight
모두보기

Century Therapeutics Inc 주식(IPSC)의 최신 뉴스

pulisher
Jul 25, 2025

What drives Century Therapeutics Inc. stock priceHigh-yield portfolio picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Century Therapeutics Inc. stockJaw-dropping returns - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Layoff Tracker: Flagship Unicorns Tessera, Generate:Biomedicines Downsize - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

Century Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 15:49:56 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 18, 2025

What institutions are buying Century Therapeutics Inc. stock nowFree Step-by-Step Investment Guide - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025
pulisher
Jul 15, 2025

Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 10, 2025
pulisher
Jul 08, 2025

Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World

Jul 08, 2025
pulisher
Jul 07, 2025

CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com

Jul 07, 2025
pulisher
Jul 07, 2025

Century Therapeutics to reduce headcount by 51% - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Century Therapeutics Announces Major Workforce Reduction - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

Century Therapeutics' Bold Restructuring: A Strategic Pivot to Deliver Transformative Therapies - AInvest

Jul 07, 2025
pulisher
Jun 25, 2025

Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - Nasdaq

Jun 25, 2025
pulisher
Jun 20, 2025

Head-To-Head Contrast: Quince Therapeutics (NASDAQ:QNCX) and Century Therapeutics (NASDAQ:IPSC) - Defense World

Jun 20, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 16, 2025
pulisher
Jun 14, 2025

66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 10, 2025

Century Therapeutics Inc (IPSC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):